Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2015 (2015), Article ID 965271, 14 pages
http://dx.doi.org/10.1155/2015/965271
Research Article

Regulation of Angiogenic Functions by Angiopoietins through Calcium-Dependent Signaling Pathways

1Department of Anatomy, Histology, Forensic Medicine and Orthopaedics, Unit of Histology and Medical Embryology, Sapienza University of Rome, 00161 Rome, Italy
2Institute of Vegetative Anatomy, Charité Universitätsmedizin, Neuromuscular Group, 10115 Berlin, Germany

Received 19 December 2014; Revised 12 February 2015; Accepted 15 February 2015

Academic Editor: Jie-Hui Li

Copyright © 2015 Irene Pafumi et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S. Fukuhara, K. Sako, K. Noda, K. Nagao, K. Miura, and N. Mochizuki, “Tie2 is tied at the cell-cell contacts and to extracellular matrix by Angiopoietin-1,” Experimental & Molecular Medicine, vol. 41, no. 3, pp. 133–139, 2009. View at Publisher · View at Google Scholar · View at Scopus
  2. S. Davis, T. H. Aldrich, P. F. Jones et al., “Isolation of angiopoietin-1, a ligand for the TIE2 receptor, by secretion-trap expression cloning,” Cell, vol. 87, no. 7, pp. 1161–1169, 1996. View at Publisher · View at Google Scholar · View at Scopus
  3. H. Huang, A. Bhat, G. Woodnutt, and R. Lappe, “Targeting the ANGPT-TIE2 pathway in malignancy,” Nature Reviews Cancer, vol. 10, no. 8, pp. 575–585, 2010. View at Publisher · View at Google Scholar · View at Scopus
  4. L. Eklund and P. Saharinen, “Angiopoietin signaling in the vasculature,” Experimental Cell Research, vol. 319, no. 9, pp. 1271–1280, 2013. View at Publisher · View at Google Scholar · View at Scopus
  5. K. J. Kim, B. Li, J. Winer et al., “Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo,” Nature, vol. 362, no. 6423, pp. 841–844, 1993. View at Publisher · View at Google Scholar · View at Scopus
  6. H. Hurwitz, L. Fehrenbacher, W. Novotny et al., “Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer,” The New England Journal of Medicine, vol. 350, no. 23, pp. 2335–2342, 2004. View at Publisher · View at Google Scholar · View at Scopus
  7. N. M. Biel and D. W. Siemann, “Targeting the Angiopoietin-2/Tie-2 axis in conjunction with VEGF signal interference,” Cancer Letters, 2014. View at Publisher · View at Google Scholar
  8. P. Carmeliet and R. K. Jain, “Principles and mechanisms of vessel normalization for cancer and other angiogenic diseases,” Nature Reviews Drug Discovery, vol. 10, no. 6, pp. 417–427, 2011. View at Publisher · View at Google Scholar · View at Scopus
  9. G. Bergers and D. Hanahan, “Modes of resistance to anti-angiogenic therapy,” Nature Reviews Cancer, vol. 8, no. 8, pp. 592–603, 2008. View at Publisher · View at Google Scholar · View at Scopus
  10. H. G. Augustin, G. Y. Koh, G. Thurston, and K. Alitalo, “Control of vascular morphogenesis and homeostasis through the angiopoietin—Tie system,” Nature Reviews Molecular Cell Biology, vol. 10, no. 3, pp. 165–177, 2009. View at Publisher · View at Google Scholar · View at Scopus
  11. M. Thomas and H. G. Augustin, “The role of the angiopoietins in vascular morphogenesis,” Angiogenesis, vol. 12, no. 2, pp. 125–137, 2009. View at Publisher · View at Google Scholar · View at Scopus
  12. P. C. Maisonpierre, C. Suri, P. F. Jones et al., “Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis,” Science, vol. 277, no. 5322, pp. 55–60, 1997. View at Publisher · View at Google Scholar · View at Scopus
  13. N. W. Gale, G. Thurston, S. F. Hackett et al., “Angiopoietin-2 is required for postnatal angiogenesis and lymphatic patterning, and only the latter role is rescued by angiopoietin-1,” Developmental Cell, vol. 3, no. 3, pp. 411–423, 2002. View at Publisher · View at Google Scholar · View at Scopus
  14. T. C. M. Seegar, B. Eller, D. Tzvetkova-Robev et al., “Tie1-Tie2 interactions mediate functional differences between angiopoietin ligands,” Molecular Cell, vol. 37, no. 5, pp. 643–655, 2010. View at Publisher · View at Google Scholar · View at Scopus
  15. G. Thurston and C. Daly, “The complex role of angiopoietin-2 in the angiopoietin-Tie signaling pathway,” Cold Spring Harbor Perspectives in Medicine, 2012. View at Publisher · View at Google Scholar · View at Scopus
  16. I. Kim, J.-H. Kim, S.-O. Moon, H. J. Kwak, N.-G. Kim, and G. Y. Koh, “Angiopoietin-2 at high concentration can enhance endothelial cell survival through the phosphatidylinositol 3′-kinase/Akt signal transduction pathway,” Oncogene, vol. 19, no. 39, pp. 4549–4552, 2000. View at Publisher · View at Google Scholar · View at Scopus
  17. K. Teichert-Kuliszewska, P. C. Maisonpierre, N. Jones et al., “Biological action of angiopoietin-2 in a fibrin matrix model of angiogenesis is associated with activation of Tie2,” Cardiovascular Research, vol. 49, no. 3, pp. 659–670, 2001. View at Publisher · View at Google Scholar · View at Scopus
  18. C. Daly, E. Pasnikowski, E. Burova et al., “Angiopoietin-2 functions as an autocrine protective factor in stressed endothelial cells,” Proceedings of the National Academy of Sciences of the United States of America, vol. 103, no. 42, pp. 15491–15496, 2006. View at Publisher · View at Google Scholar · View at Scopus
  19. K. Fujikawa, I. de Aos Scherpenseel, S. K. Jain, E. Presman, R. A. Christensen, and L. Varticovski, “Role of PI 3-kinase in angiopoietin-1-mediated migration and attachment-dependent survival of endothelial cells,” Experimental Cell Research, vol. 253, no. 2, pp. 663–672, 1999. View at Publisher · View at Google Scholar
  20. I. Kim, H. G. Kim, J.-N. So, J. H. Kim, H. J. Kwak, and G. Y. Koh, “Angiopoietin-1 regulates endothelial cell survival through the phosphatidylinositol 3′-kinase/Akt signal transduction pathway,” Circulation Research, vol. 86, no. 1, pp. 24–29, 2000. View at Publisher · View at Google Scholar · View at Scopus
  21. D. P. Hughes, M. B. Marron, and N. P. J. Brindle, “The antiinflammatory endothelial tyrosine kinase Tie2 interacts with a novel nuclear factor-κB inhibitor ABIN-2,” Circulation Research, vol. 92, no. 6, pp. 630–636, 2003. View at Publisher · View at Google Scholar · View at Scopus
  22. U. Fiedler, M. Scharpfenecker, S. Koidl et al., “The Tie-2 ligand Angiopoietin-2 is stored in and rapidly released upon stimulation from endothelial cell Weibel-Palade bodies,” Blood, vol. 103, no. 11, pp. 4150–4156, 2004. View at Publisher · View at Google Scholar · View at Scopus
  23. Y.-Q. Huang, J.-J. Li, L. Hu, M. Lee, and S. Karpatkin, “Thrombin induces increased expression and secretion of angiopoietin-2 from human umbilical vein endothelial cells,” Blood, vol. 99, no. 5, pp. 1646–1650, 2002. View at Publisher · View at Google Scholar · View at Scopus
  24. I. Helfrich, L. Edler, A. Sucker et al., “Angiopoietin-2 levels are associated with disease progression in metastatic malignant melanoma,” Clinical Cancer Research, vol. 15, no. 4, pp. 1384–1392, 2009. View at Publisher · View at Google Scholar · View at Scopus
  25. K. M. Detjen, S. Rieke, A. Deters et al., “Angiopoietin-2 promotes disease progression of neuroendocrine tumors,” Clinical Cancer Research, vol. 16, no. 2, pp. 420–429, 2010. View at Publisher · View at Google Scholar · View at Scopus
  26. V. Goede, O. Coutelle, J. Neuneier et al., “Identification of serum angiopoietin-2 as a biomarker for clinical outcome of colorectal cancer patients treated with bevacizumab-containing therapy,” British Journal of Cancer, vol. 103, no. 9, pp. 1407–1414, 2010. View at Publisher · View at Google Scholar · View at Scopus
  27. S. Fukuhara, K. Sako, T. Minami et al., “Differential function of Tie2 at cell-cell contacts and cell-substratum contacts regulated by angiopoietin-1,” Nature Cell Biology, vol. 10, no. 5, pp. 513–526, 2008. View at Publisher · View at Google Scholar · View at Scopus
  28. M. J. Berridge, M. D. Bootman, and H. L. Roderick, “Calcium signalling: dynamics, homeostasis and remodelling,” Nature Reviews Molecular Cell Biology, vol. 4, no. 7, pp. 517–529, 2003. View at Publisher · View at Google Scholar · View at Scopus
  29. A. Galione and G. C. Churchill, “Interactions between calcium release pathways: multiple messengers and multiple stores,” Cell Calcium, vol. 32, no. 5-6, pp. 343–354, 2002. View at Publisher · View at Google Scholar · View at Scopus
  30. A. J. Morgan, F. M. Platt, E. Lloyd-Evans, and A. Galione, “Molecular mechanisms of endolysosomal Ca2+ signalling in health and disease,” Biochemical Journal, vol. 439, no. 3, pp. 349–374, 2011. View at Publisher · View at Google Scholar · View at Scopus
  31. B. Esposito, G. Gambara, A. M. Lewis et al., “NAADP links histamine H1 receptors to secretion of von Willebrand factor in human endothelial cells,” Blood, vol. 117, no. 18, pp. 4968–4977, 2011. View at Publisher · View at Google Scholar · View at Scopus
  32. A. Favia, M. Desideri, G. Gambara et al., “VEGF-induced neoangiogenesis is mediated by NAADP and two-pore channel-2-dependent Ca2+ signaling,” Proceedings of the National Academy of Sciences of the United States of America, vol. 111, no. 44, pp. E4706–E4715, 2014. View at Publisher · View at Google Scholar
  33. G. Grynkiewicz, M. Poenie, and R. Y. Tsien, “A new generation of Ca2+ indicators with greatly improved fluorescence properties,” The Journal of Biological Chemistry, vol. 260, no. 6, pp. 3440–3450, 1985. View at Google Scholar · View at Scopus
  34. M. J. Berridge, “Inositol trisphosphate and calcium signalling mechanisms,” Biochimica et Biophysica Acta—Molecular Cell Research, vol. 1793, no. 6, pp. 933–940, 2009. View at Publisher · View at Google Scholar · View at Scopus
  35. M. Brini and E. Carafoli, “Calcium pumps in health and disease,” Physiological Reviews, vol. 89, no. 4, pp. 1341–1378, 2009. View at Publisher · View at Google Scholar · View at Scopus
  36. A. Papapetropoulos, D. Fulton, K. Mahboubi et al., “Angiopoietin-1 inhibits endothelial cell apoptosis via the Akt/survivin pathway,” The Journal of Biological Chemistry, vol. 275, no. 13, pp. 9102–9105, 2000. View at Publisher · View at Google Scholar · View at Scopus
  37. W.-H. Zhu, J. Han, and R. F. Nicosia, “Requisite role of p38 MAPK in mural cell recruitment during angiogenesis in the rat aorta model,” Journal of Vascular Research, vol. 40, no. 2, pp. 140–148, 2003. View at Publisher · View at Google Scholar · View at Scopus
  38. P. Saharinen, L. Eklund, J. Miettinen et al., “Angiopoietins assemble distinct Tie2 signalling complexes in endothelial cell-cell and cell-matrix contacts,” Nature Cell Biology, vol. 10, no. 5, pp. 527–537, 2008. View at Publisher · View at Google Scholar · View at Scopus
  39. W. H. Zhu, A. MacIntyre, and R. F. Nicosia, “Regulation of angiogenesis by vascular endothelial growth factor and angiopoietin-1 in the rat aorta model: distinct temporal patterns of intracellular signaling correlate with induction of angiogenic sprouting,” The American Journal of Pathology, vol. 161, no. 3, pp. 823–830, 2002. View at Publisher · View at Google Scholar · View at Scopus
  40. I. Kim, H. G. Kim, S. O. Moon et al., “Angiopoietin-1 induces endothelial cell sprouting through the activation of focal adhesion kinase and plasmin secretion,” Circulation Research, vol. 86, no. 9, pp. 952–959, 2000. View at Publisher · View at Google Scholar · View at Scopus
  41. M. Felcht, R. Luck, A. Schering et al., “Angiopoietin-2 differentially regulates angiogenesis through TIE2 and integrin signaling,” The Journal of Clinical Investigation, vol. 122, no. 6, pp. 1991–2005, 2012. View at Publisher · View at Google Scholar · View at Scopus
  42. I. Cascone, E. Audero, E. Giraudo et al., “Tie-2-dependent activation of RhoA and Rac1 participates in endothelial cell motility triggered by angiopoietin-1,” Blood, vol. 102, no. 7, pp. 2482–2490, 2003. View at Publisher · View at Google Scholar · View at Scopus
  43. B. Witzenbichler, P. C. Maisonpierre, P. Jones, G. D. Yancopoulos, and J. M. Isner, “Chemotactic properties of angiopoietin-1 and -2, ligands for the endothelial-specific receptor tyrosine kinase Tie2,” The Journal of Biological Chemistry, vol. 273, no. 29, pp. 18514–18521, 1998. View at Publisher · View at Google Scholar · View at Scopus
  44. C. A. Staton, M. W. R. Reed, and N. J. Brown, “A critical analysis of current in vitro and in vivo angiogenesis assays,” International Journal of Experimental Pathology, vol. 90, no. 3, pp. 195–221, 2009. View at Publisher · View at Google Scholar · View at Scopus
  45. E. Fagiani and G. Christofori, “Angiopoietins in angiogenesis,” Cancer Letters, vol. 328, no. 1, pp. 18–26, 2013. View at Publisher · View at Google Scholar · View at Scopus